Psyadon Pharmaceuticals
Latest round
- Series A
Last raised
- Nov 2008
Total raised
- $11M
Investors
- 3
About Psyadon Pharmaceuticals
Psyadon Pharmaceuticals, Inc.Founded in 2004 in Germantown, US, Psyadon Pharmaceuticals focuses on developing aesthetic solutions for male enhancement.The company specializes in penile enhancement procedures, specifically focusing on glans enlargement through the injection of hyaluronic acid. This minimally invasive treatment increases both the size and firmness of the glans, typically lasting about 10 minutes. Clients enjoy a discreet enhancement with no downtime, enabling them to shower on the same day.Psyadon Pharmaceuticals generates revenue through direct transactions with clients seeking glans enlargement services. Each procedure is priced per injection, with clients typically purchasing one to two syringes of hyaluronic acid per session. The company operates on a direct-to-consumer model, providing services through its clinics where customers receive personalized treatment plans.Psyadon Pharmaceuticals is focused on expanding its product offerings and market reach. The company is designing new enhancements to complement its existing glans enlargement procedure, though specific release dates have not been disclosed. Additionally, Psyadon aims to enter new markets, particularly targeting regions in East Asia, by 2025 to capitalize on the growing acceptance of aesthetic procedures.
Who invested in Psyadon Pharmaceuticals
3 investors across 2 rounds
See all investors in Psyadon Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Psyadon Pharmaceuticals
Who invested in Psyadon Pharmaceuticals?
Psyadon Pharmaceuticals has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Psyadon Pharmaceuticals raised?
Psyadon Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Psyadon Pharmaceuticals last raise money?
Psyadon Pharmaceuticals's most recent round on record is a Series A, in Nov 2008.
What does Psyadon Pharmaceuticals do?
Psyadon Pharmaceuticals is a pharmaceuticals company.
Where is Psyadon Pharmaceuticals headquartered?
Psyadon Pharmaceuticals is headquartered in Germantown, US.
Which VCs invest in companies like Psyadon Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Psyadon Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Psyadon Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.